N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: Initial experience
- 14 June 2013
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 23 (11) , 3161-3169
Abstract
Evaluate the performance of PET/MRI at tissue interfaces with different attenuation values for detecting lymph node (LN) metastases and for accurately measuring maximum standardised uptake values (SUVmax) in lung cancer patients.Keywords
This publication has 21 references indexed in Scilit:
- Standardized uptake values for [18F] FDG in normal organ tissues: Comparison of whole-body PET/CT and PET/MRIEuropean Journal of Radiology, 2013
- Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correctionMagnetic Resonance Materials in Physics, Biology and Medicine, 2012
- Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter studyRadiotherapy and Oncology, 2012
- Staging of non-small cell lung cancer (NSCLC): A reviewRespiratory Medicine, 2010
- Whole-Body PET/CT Scanning: Estimation of Radiation Dose and Cancer RiskRadiology, 2009
- Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non–small cell lung cancer with fewer false-positive resultsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- ESTS guidelines for preoperative lymph node staging for non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2007
- Understanding interobserver agreement: the kappa statistic.2005
- Correlation and Simple Linear RegressionRadiology, 2003